+49 171 1049 181 [email protected]

Organizing Committee

  • Karen Elkins, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, USA (Co-Chair)
  • Catharine (Katy) Bosio, NIAID, Rocky Mountain Labs, Hamilton, Montana, USA (Co-Chair)
  • Lee-Ann Allen, University of Iowa, USA
  • Wayne Conlan, National Research Council, Canada Canada (ex officio as TULISOC President)
  • Roberto De Pascalis, CBER / FDA, USA
  • Jason Huntley, University of Toledo, USA
  • Tom Kawula, Washington State University, USA
  • Karl Klose, University of Texas-San Antonio, USA
  • Max Maurin, Université Grenoble Alpes, France
  • Petra Oyston, Defence Science and Technology Laboratory, United Kingdom
  • Jeannine Petersen, Centers for Disease Control, USA
  • Marina Šantić, University of Rijeka, Croatia
  • Jiri Stulik, University of Defence , Czech Republic

Session Chairs:

  • Lee-Ann Allen, University of Iowa, Iowa City, United States
  • Catharine Bosio, Rocky Mountain Laboratories, Hamilton, United States
  • Simon Dove, Boston Childrens Hospital, Harvard Medical School, Boston United States
  • Raquel Escudero, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain
  • Thomas Henry, CIRI, International Center for Infectiology Research, Lyon, France
  • Selçuk Kiliç, Public Health Institution of Turkey, Ankara, Turkey
  • Karl Klose, University of Texas San Antonio, San Antonio, United States
  • Kiersten Kugeler, Centers for Disease Control and Prevention, Fort Collins, United States
  • Helena Lindgren, Umeå University, UMEÅ, Sweden
  • Max Maurin, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France
  • Petra Oyston, Dstl, Salisbury, United Kingdom
  • Marina Šantić, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
  • Terry Wu, University of New Mexico Health Sciences Center, Albuquerque, United States